CoChat
Sign Up
Cited by 285Medicinal Plants and NeuroprotectionAlzheimer's disease research and treatmentsGinkgo biloba and Cashew Applications

The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.

Medicinal plants and Alzheimer’s disease: From ethnobotany to phytotherapy

Open access
Perry, Elaine K, Pickering, Anne T, Wang, Wei Wei, Houghton, Peter J, Perry, Nicolette S L·1999·Journal of Pharmacy and Pharmacology
DOI 10.1211/0022357991772808
Open this paper in CoChat — free account

Abstract

The use of complementary medicines, such as plant extracts, in dementia therapy varies according to the different cultural traditions. In orthodox Western medicine, contrasting with that in China and the Far East for example, pharmacological properties of traditional cognitive- or memory-enhancing plants have not been widely investigated in the context of current models of Alzheimer's disease. An exception is Gingko biloba in which the gingkolides have antioxidant, neuroprotective and cholinergic activities relevant to Alzheimer's disease mechanisms. The therapeutic efficacy of Ginkgo extracts in Alzheimer's disease in placebo controlled clinical trials is reportedly similar to currently prescribed drugs such as tacrine or donepezil and, importantly, undesirable side effects of Gingko are minimal. Old European reference books, such as those on medicinal herbs, document a variety of other plants such as Salvia officinalis (sage) and Melissa officinalis (balm) with memory-improving properties, and cholinergic activities have recently been identified in extracts of these plants. Precedents for modern discovery of clinically relevant pharmacological activity in plants with long-established medicinal use include, for example, the interaction of alkaloid opioids in Papaver somniferum (opium poppy) with endogenous opiate receptors in the brain. With recent major advances in understanding the neurobiology of Alzheimer's disease, and as yet limited efficacy of so-called rationally designed therapies, it may be timely to re-explore historical archives for new directions in drug development. This article considers not only the value of an integrative traditional and modern scientific approach to developing new treatments for dementia, but also in the understanding of disease mechanisms. Long before the current biologically-based hypothesis of cholinergic derangement in Alzheimer' s disease emerged, plants now known to contain cholinergic antagonists were recorded for their amnesia- and dementia-inducing properties.

Overview

Integrity signals

Registry

Crossref · 10.1211/0022357991772808

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 14

  1. Bhattacharya, 1995, Effect of MentatR, a herbal formulation, on experimental models of Alzheimer's disease and central cholinergic markers in rats, Fitoterapia, 66, 216
  2. Burkard, 1991, Verhaltnis Von demenzen vom multinfarkt und vom Alzheimertyp in arzlichen praxen. Diagnostische und Therapeutische Konsequenzen am beispiel eines Ginkgobiloba praparates, Munch. Med. Wschr., 133, 38
  3. Coghan, 1584, The Haven of Health
  4. Culpeper, 1652, Culpeper's Complete Herbal: consisting of a comprehensive description of nearly all herbs with their medicinal properties
  5. Evelyn, 1699, Acetaria
  6. Everard, 1659, Panacea or the Universal Medicine
  7. Gerard, 1876, A catalogue of Plants (1596-1599)
  8. Grieve, 1931, A Modern Herbal
  9. Hill, 1755, The Family Herbal
  10. Hwang, 1996, An acetylcholinesterase inhibitor isolated from corydalis tuber and its mode of action, Korean J. Pharmacog., 27, 91
  11. McIntyre, 1996, The Complete Floral Healer
  12. Mitchell, 1993, Aromatherapy's effectiveness in disorders associated with dementia, Int. J. Aromatherapy, 5, 20
  13. Taylor, 1986, Neuromediator binding to receptors in the rat brain, The effect of chronic administration of Ginkgo biloba extract. Presse Medicale-Paris, 15, 1491
  14. Xu, 1995, Efficacy of tablet huperzine-A on memory, cognition and behaviour in Alzheimer's disease, Chung-Kuo Yao Li Hsueh Pao-Acta Pharmacologica Sinica, 16, 391

Cited by

Sorted by citations

See all 285

Related

See all

Metadata

Authors
Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P. J., & Perry, N. S. L.
Affiliations
  • Medical Research Council (GB)
  • Newcastle University (GB)
  • King's College London (GB)
Corresponding author
Perry, Elaine K
ORCID
Wang, Wei Wei
Venue
Journal of Pharmacy and Pharmacology
Publisher
Oxford University Press (OUP)
Published
1999-05-01
Volume
51
Issue
5
Pages
527-534
ISSN
  • 0022-3573 (ISSN-L)
  • 2042-7158
DOI
10.1211/0022357991772808
OpenAlex
W1997343208
Cited by
285
References
45
Citations by year
2026: 4 · 2025: 10 · 2024: 14 · 2023: 14 · 2022: 9 · 2021: 13 · 2020: 12 · 2019: 13 · 2018: 15 · 2017: 13 · 2016: 8 · 2015: 7 · 2014: 17 · 2013: 12 · 2012: 10
FWCI
7.71
Type
journal article
Language
en
Open access
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations
  • Journal of Pharmacy and Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
Keywords
Alzheimer's disease, medicinal plants, ethnobotany, herbal medicine, Ginkgo biloba, cholinergic activity, Salvia officinalis, lemon balm, memory enhancement, traditional medicine, dementia, drug development, cholinergic hypothesis, neuroprotection, antioxidant activity
MeSH terms
Alzheimer Disease, China, Dementia, Humans, Medicine, Chinese Traditional, Phytotherapy, Plants, Medicinal, Saliva, Cholinergic Agents, Ethnobotany, Ginkgo biloba

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review